Soultana Christou

Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study

Eleni‐Kyriaki Vetsika, Soultana Christou, Dora Hatzidaki et al. · Annals of Oncology · 2011 · 50 citations · Full text

Medicine, Immunology, Oncology +16

Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001

Eleni‐Kyriaki Vetsika, Georgios Konsolakis, Despoina Aggouraki et al. · Cancer Immunology Immunotherapy · 2011 · 44 citations · Full text

Medicine, Immunology, Oncology +16

Sequential Administration of the Native TERT572 Cryptic Peptide Enhances the Immune Response Initiated by its Optimized Variant TERT572Y in Cancer Patients

Eleni‐Kyriaki Vetsika, E. Papadimitraki, Despoina Aggouraki et al. · Journal of Immunotherapy · 2011 · 13 citations

Life Sciences, Immunology, Oncology +17